Combination therapy efavirenz/emtricitabine/tenofovir disoproxil fumarate associated with hepatic failure.

@article{Qayyum2012CombinationTE,
  title={Combination therapy efavirenz/emtricitabine/tenofovir disoproxil fumarate associated with hepatic failure.},
  author={Sohail Qayyum and Huijun Dong and Dianne Kovacic and Sidra Sohail and Bradford Waters and Camille Thornton and Cathy E Corbett},
  journal={Current drug safety},
  year={2012},
  volume={7 5},
  pages={391-3}
}
A single pill daily fixed dose combination of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate (EFV/FTC/TDF) provides a potent and convenient treatment option for HIV/AIDS. The components have been shown to be well tolerated and are effective in randomized controlled trials. A literature search revealed no case of hepatic failure reported with… CONTINUE READING